価格表

在庫・価格 : 2026年04月06日 21時31分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Trance, Mouse-Mono(12A668)
データシート
NB100-56512 NOVノバス バイオロジカルス
Novus biologicals, LLC
0.1 mg ¥101,000
(未発注)
追加

在庫・価格 : 2026年04月06日 21時31分 現在

Anti-Trance, Mouse-Mono(12A668)

  • 商品コード:NB100-56512
  • メーカー:NOV
  • 包装:0.1mg
  • 価格: ¥101,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Yin Y et al. Lesional infiltration of receptor activator of nuclear factor-κB ligand(+) cells in experimental autoimmune neuritis rats. Neurol Sci 2012 Jul;
Yin Y et al
2012/01/01
Species: Rat, Applications: IHC PubMed
2 Hu P et al. Multiplexed quantum dot labeling of activated c-Met signaling in castration-resistant human prostate cancer. PLoS ONE 2011;6(12):e28670
Hu P et al
2011/01/01
Species: Human, Applications: IHC, IF PubMed
3 Pearse RN et al. Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression. Proc. Natl. Acad. Sci. U.S.A. 2001 Sep;98(20):11581-6
Pearse RN et al
2001/01/01
PubMed
4 Hu P et al. Convergent RANK- and c-Met-mediated signaling components predict survival of patients with prostate cancer: an interracial comparative study. PLoS ONE 2013;8(9):e73081
Hu P et al
2013/01/01
Species: Human PubMed
5 Kikuchi T et al. Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors. J. Immunol. 2001 Mar;166(5):3574-9
Kikuchi T et al
2001/01/01
PubMed
6 Shin M et al. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells. Carcinogenesis 2011 Nov;32(11):1634-40
Shin M et al
2011/01/01
PubMed
7 Sandra F et al. Ameloblastoma induces osteoclastogenesis: a possible role of ameloblastoma in expanding in the bone. Oral Oncol. 2005 Jul;41(6):637-44
Sandra F et al
2005/01/01
PubMed
8 Ghoreishi M et al. Expansion of antigen-specific regulatory T cells with the topical vitamin d analog calcipotriol. J. Immunol. 2009 May;182(10):6071-8
Ghoreishi M et al
2009/01/01
PubMed
9 Fiumara P et al. Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines. Blood 2001 Nov;98(9):2784-90
Fiumara P et al
2001/01/01
PubMed
10 Rubin J et al. Prostate carcinoma cells that have resided in bone have an upregulated IGF-I axis. Prostate 2004 Jan;58(1):41-9
Rubin J et al
2004/01/01
PubMed
11 Niida S et al. Gamma-glutamyltranspeptidase stimulates receptor activator of nuclear factor-kappaB ligand expression independent of its enzymatic activity and serves as a pathological bone-resorbing factor. J. Biol. Chem. 2004 Feb;279(7):5752-6
Niida S et al
2004/01/01
PubMed
12 Parrula C et al. Expression of tumor invasion factors determines systemic engraftment and induction of humoral hypercalcemia in a mouse model of adult T-cell leukemia. Vet. Pathol. 2009 Sep;46(5):1003-14
Parrula C et al
2009/01/01
PubMed
13 Neidhart M et al. Expression of cathepsin K and matrix metalloproteinase 1 indicate persistent osteodestructive activity in long-standing ankylosing spondylitis. Ann. Rheum. Dis. 2009 Aug;68(8):1334-9
Neidhart M et al
2009/01/01
PubMed
14 Gambichler T et al. T regulatory cells and related immunoregulatory factors in polymorphic light eruption following ultraviolet A1 challenge. Br. J. Dermatol. 2013 Dec;169(6):1288-94
Gambichler T et al
2013/01/01
PubMed
15 Kim RY et al. The effect of dose on rhBMP-2 signaling, delivered via collagen sponge, on osteoclast activation and in vivo bone resorption. Biomaterials 2014 Feb;35(6):1869-81
Kim RY et al
2014/01/01
PubMed
16 Boyce AM et al. Denosumab treatment for fibrous dysplasia. J. Bone Miner. Res. 2012 Jul;27(7):1462-70
Boyce AM et al
2012/01/01
PubMed
17 Mine Y et al. Involvement of ERK and p38 MAPK pathways on Interleukin-33-induced RANKL expression in osteoblastic cells. Cell Biol. Int. 2014 May;38(5):655-62
Mine Y et al
2014/01/01
Species: Mouse, Applications: WB PubMed
18 Callegari A et al. Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6. J. Vasc. Res. 2014;51(2):118-31
Callegari A et al
2014/01/01
Species: Mouse, Applications: IHC-P PubMed
19 Shao J et al. HIF-1α disturbs osteoblasts and osteoclasts coupling in bone remodeling by up-regulating OPG expression. In Vitro Cell. Dev. Biol. Anim. 2015 Sep;51(8):808-14
Shao J et al
2015/01/01
Species: Mouse, Applications: WB, ChIP PubMed
20 Tanaka T et al. RANKL-mediated osteoclastogenic differentiation of macrophages in the abdominal aorta of angiotensin II-infused apolipoprotein E knockout mice. J. Vasc. Surg. 2018 Dec;68(6S):48S-59S.e1
Tanaka T et al
2018/01/01
Species: Mouse, Applications: ICC/IF PubMed
21 Hsu H et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc. Natl. Acad. Sci. U.S.A. 1999 Mar;96(7):3540-5
Hsu H et al
1999/01/01
PubMed
22 Gunji H et al. Effect of high-frequency near-infrared diode laser irradiation on periodontal tissues during experimental tooth movement in rats. Lasers Surg Med 2018 Feb;
Gunji H et al
2018/01/01
Species: Rat, Applications: PubMed
23 Liu X et al. Spatiotemporal characterization of microdamage accumulation and its targeted remodeling mechanisms in diabetic fatigued bone. FASEB J 2020 02;34(2):2579-2594
Liu X et al
2020/01/01
PubMed
24 Hong H et al. Intermittent hypoxia retards mandibular growth and alters RANKL expression in adolescent and juvenile rats. Eur J Orthod 2020 Mar;
Hong H et al
2020/01/01
PubMed
25 Kunimatsu R et al. Baicalin inhibits root resorption during tooth movement in a rodent model. Arch Oral Biol 2020 Aug;116:104770
Kunimatsu R et al
2020/01/01
PubMed
26 Nakao Y et al. Exosomes from TNF-α-treated human gingiva-derived MSCs enhance M2 macrophage polarization and inhibit periodontal bone loss. Acta Biomater 2021 03;122:306-324
Nakao Y et al
2021/01/01
PubMed
27 Liu X et al. Distinct human Langerhans cell subsets orchestrate reciprocal functions and require different developmental regulation. Immunity 2021 10;54(10):2305-2320.e11
Liu X et al
2021/01/01
PubMed
28 Gegen T et al. Role of interleukin-33 in the clinical pathogenesis of chronic apical periodontitis. J. Int. Med. Res. 2019 Jul;47(7):3332-3343
Gegen T et al
2019/01/01
Species: Human, Applications: IHC PubMed
  • No.: 1
  • 文献情報:
    Yin Y et al. Lesional infiltration of receptor activator of nuclear factor-κB ligand(+) cells in experimental autoimmune neuritis rats. Neurol Sci 2012 Jul;
    Yin Y et al
    2012/01/01
  • 備考:
    Species: Rat, Applications: IHC
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Hu P et al. Multiplexed quantum dot labeling of activated c-Met signaling in castration-resistant human prostate cancer. PLoS ONE 2011;6(12):e28670
    Hu P et al
    2011/01/01
  • 備考:
    Species: Human, Applications: IHC, IF
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Pearse RN et al. Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression. Proc. Natl. Acad. Sci. U.S.A. 2001 Sep;98(20):11581-6
    Pearse RN et al
    2001/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Hu P et al. Convergent RANK- and c-Met-mediated signaling components predict survival of patients with prostate cancer: an interracial comparative study. PLoS ONE 2013;8(9):e73081
    Hu P et al
    2013/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Kikuchi T et al. Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors. J. Immunol. 2001 Mar;166(5):3574-9
    Kikuchi T et al
    2001/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Shin M et al. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells. Carcinogenesis 2011 Nov;32(11):1634-40
    Shin M et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Sandra F et al. Ameloblastoma induces osteoclastogenesis: a possible role of ameloblastoma in expanding in the bone. Oral Oncol. 2005 Jul;41(6):637-44
    Sandra F et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Ghoreishi M et al. Expansion of antigen-specific regulatory T cells with the topical vitamin d analog calcipotriol. J. Immunol. 2009 May;182(10):6071-8
    Ghoreishi M et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Fiumara P et al. Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines. Blood 2001 Nov;98(9):2784-90
    Fiumara P et al
    2001/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Rubin J et al. Prostate carcinoma cells that have resided in bone have an upregulated IGF-I axis. Prostate 2004 Jan;58(1):41-9
    Rubin J et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Niida S et al. Gamma-glutamyltranspeptidase stimulates receptor activator of nuclear factor-kappaB ligand expression independent of its enzymatic activity and serves as a pathological bone-resorbing factor. J. Biol. Chem. 2004 Feb;279(7):5752-6
    Niida S et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Parrula C et al. Expression of tumor invasion factors determines systemic engraftment and induction of humoral hypercalcemia in a mouse model of adult T-cell leukemia. Vet. Pathol. 2009 Sep;46(5):1003-14
    Parrula C et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Neidhart M et al. Expression of cathepsin K and matrix metalloproteinase 1 indicate persistent osteodestructive activity in long-standing ankylosing spondylitis. Ann. Rheum. Dis. 2009 Aug;68(8):1334-9
    Neidhart M et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Gambichler T et al. T regulatory cells and related immunoregulatory factors in polymorphic light eruption following ultraviolet A1 challenge. Br. J. Dermatol. 2013 Dec;169(6):1288-94
    Gambichler T et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Kim RY et al. The effect of dose on rhBMP-2 signaling, delivered via collagen sponge, on osteoclast activation and in vivo bone resorption. Biomaterials 2014 Feb;35(6):1869-81
    Kim RY et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Boyce AM et al. Denosumab treatment for fibrous dysplasia. J. Bone Miner. Res. 2012 Jul;27(7):1462-70
    Boyce AM et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Mine Y et al. Involvement of ERK and p38 MAPK pathways on Interleukin-33-induced RANKL expression in osteoblastic cells. Cell Biol. Int. 2014 May;38(5):655-62
    Mine Y et al
    2014/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Callegari A et al. Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6. J. Vasc. Res. 2014;51(2):118-31
    Callegari A et al
    2014/01/01
  • 備考:
    Species: Mouse, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Shao J et al. HIF-1α disturbs osteoblasts and osteoclasts coupling in bone remodeling by up-regulating OPG expression. In Vitro Cell. Dev. Biol. Anim. 2015 Sep;51(8):808-14
    Shao J et al
    2015/01/01
  • 備考:
    Species: Mouse, Applications: WB, ChIP
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Tanaka T et al. RANKL-mediated osteoclastogenic differentiation of macrophages in the abdominal aorta of angiotensin II-infused apolipoprotein E knockout mice. J. Vasc. Surg. 2018 Dec;68(6S):48S-59S.e1
    Tanaka T et al
    2018/01/01
  • 備考:
    Species: Mouse, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Hsu H et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc. Natl. Acad. Sci. U.S.A. 1999 Mar;96(7):3540-5
    Hsu H et al
    1999/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Gunji H et al. Effect of high-frequency near-infrared diode laser irradiation on periodontal tissues during experimental tooth movement in rats. Lasers Surg Med 2018 Feb;
    Gunji H et al
    2018/01/01
  • 備考:
    Species: Rat, Applications:
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Liu X et al. Spatiotemporal characterization of microdamage accumulation and its targeted remodeling mechanisms in diabetic fatigued bone. FASEB J 2020 02;34(2):2579-2594
    Liu X et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Hong H et al. Intermittent hypoxia retards mandibular growth and alters RANKL expression in adolescent and juvenile rats. Eur J Orthod 2020 Mar;
    Hong H et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Kunimatsu R et al. Baicalin inhibits root resorption during tooth movement in a rodent model. Arch Oral Biol 2020 Aug;116:104770
    Kunimatsu R et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Nakao Y et al. Exosomes from TNF-α-treated human gingiva-derived MSCs enhance M2 macrophage polarization and inhibit periodontal bone loss. Acta Biomater 2021 03;122:306-324
    Nakao Y et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Liu X et al. Distinct human Langerhans cell subsets orchestrate reciprocal functions and require different developmental regulation. Immunity 2021 10;54(10):2305-2320.e11
    Liu X et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Gegen T et al. Role of interleukin-33 in the clinical pathogenesis of chronic apical periodontitis. J. Int. Med. Res. 2019 Jul;47(7):3332-3343
    Gegen T et al
    2019/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed